We are thrilled to announce that an abstract from the Institute of Cancer and Crisis has been accepted for presentation at the World Cancer Congress 2024 in Geneva!
Jemma Arakelyan, CEO at the Institute of Cancer and Crisis, shared a post by on LinkedIn:
“Proud of our amazing team at the Institute of Cancer and Crisis! Kind-hearted and hard-working individuals coming together to make a difference.”
Quoting
“Exciting News!
We are thrilled to announce that an abstract from the Institute of Cancer and Crisis has been accepted for presentation at the World Cancer Congress 2024 in Geneva! The abstract titled ‘Quality of Life of Cancer Patients with Comorbidities – A Mixed-Methods Study’ sheds light on an important aspect of cancer care, focusing on the impact of comorbidities on the quality of life of cancer patients.
Stay tuned for more updates from the World Cancer Congress 2024, where experts from around the globe will gather to share knowledge, exchange ideas, and work towards a world without cancer.”
Source: Jemma Arakelyan/LinkedIn and
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”